Skip to content
Open access

Clustered structural variant hotspots enable oncogenic addiction and plasticity in osteosarcoma

Sep 2026 · bioRxiv · 0 citations · 45 references
Medicine Biology

TL;DR

Across 236 whole-genome sequencing osteosarcoma samples, five genomic hotspots of clustered structural variation collectively altered in 58% of tumors were uncovered, and localized transcriptional dysregulation at hotspot event loci was found, linking these structural alterations to a less differentiated cell state.

Abstract

The genomic landscape of osteosarcoma, the most common bone cancer worldwide, is among the most structurally complex of all human malignancies. The identification of recurrent and functionally consequential patterns has thus remained a challenge. Across 236 whole-genome sequencing osteosarcoma samples, we uncovered five genomic hotspots of clustered structural variation collectively altered in 58% of tumors. Four were associated with amplification of oncogenes (MYC, CCND3, CCNE1, CDK4), while the fifth mapped largely upstream of TP53. Hotspot events showed coordinated patterns of co-occurrence and mutual exclusivity with each other and with tumor suppressor alterations, suggesting genomic context-specific selection. We found localized transcriptional dysregulation at hotspot event loci, and single cells harboring these events converged on a neural crest-like program, linking these structural alterations to a less differentiated cell state. These events were also detectable non-invasively through liquid biopsies and displayed ongoing structural evolution throughout disease progression, a finding with potential clinical utility. Our results provide novel insight into how complex rearrangements shape oncogenesis in osteosarcoma, with broader relevance to other cancers characterized by complex genomes.

Read PDF

Similar papers

Open access Sep 2026

Recurrent deletions and regulatory disruption of the Y chromosome in cancer

High-coverage whole-genome sequencing, large-scale transcriptomics, and eQTL are used to map male cancer cell lines, revealing a region-specific LOY landscape with recurrent euchromatic deletions affecting protein-coding genes and non-coding elements and motivating validation in primary tumor cohorts.

Trini Nguyen, Aditi Kuchi, Hong-Yu Liu et al. · 0 citations
Open access Aug 2026

Comprehensive genomic profiling of mucosal melanoma reveals novel fusion transcripts and dysregulation of cell‐cycle, MAPK, and PI3K pathways

It is proposed that MEK inhibitors may represent a relevant therapeutic option for BRAF fusions and non‐V600 BRAF mutant tumours, providing a novel strategy for this challenging disease.

Matilde Monti, Martina Brigida Romanello, L. Agnelli et al. · 0 citations
#gene editing Review Open access Aug 2026

Mutational Landscape and Regulatory Network Analysis of TP53 and FOXA1 in Prostate Cancer

TP53 and FOXA1 mutations, observed in primary and metastatic castration-resistant prostate cancer, were associated with aggressive disease phenotypes and potential therapeutic resistance, and these findings highlight TP53 and FOXA1 as promising biomarkers and potential therapeutic targets in prostate cancer.

Shrijee Lakshkar, Pratha Tiwari, Heenal Bhatt et al. · 0 citations
Open access Aug 2026

Multi◻region whole◻genome and transcriptomic profiling uncovers plastic, subclone◻linked cell states in high◻grade diffuse astrocytomas

A framework for understanding how early-established genomic backbones and regional transcriptional plasticity jointly drive phenotypic diversity is provided for understanding how genomic diversification intersects with transcriptional plasticity remains incompletely understood.

Serafiina Ohlsbom, S. Mäntylä, R. Nätkin et al. · 0 citations
Open access Sep 2026

Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer

The data suggest that despite the heterogeneity in CRC, genomic evolution increases the impact of recurrent alterations, and integrating information about tumor primary location and genomics can be used to predict organ-specific metastasis risk.

Paolo Manca, H. Walch, Jierui Xu et al. · 1 citation
Review Open access Sep 2026

THE ROLE OF CHROMOSOMAL TRANSLOCATIONS IN HEMATOLOGIC MALIGNANCIES: MECHANISTIC INSIGHTS AND CLINICAL CORRELATES

Chromosomal translocations are central drivers of hematologic malignancies, reshaping gene regulation, altering epigenetic states, and generating oncogenic fusion proteins that initiate and sustain malignant transformation. Advances in whole-genome sequencing, long-read mapping, and single-cell multiomics have expanded...

E. I. Obeagu, Abraham John Chuwkwuebuka, E. Abdalhabib · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.